Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
810.00Prev. Close
813.65Volume
496Total traded value
0.04 CrUpper Circuit
976.35Lower Circuit
650.95Fundamentals
| Market Cap | ₹463Cr |
| ROE | -3.83% |
| P/E Ratio(TTM) | -30.68 |
| EPS(TTM) | -26.41 |
| P/B Ratio | 1.17 |
| Dividend Yield | 0.62% |
| Industry P/E | 40.46 |
| Book Value | 689.84 |
| Debt to Equity | 0.11 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Albert David
Albert David Limited is a trusted pharmaceutical company with a successful operational history spanning over eight decades in India. Its core mission is to deliver excellence through innovation by employing cutting-edge technology and methodologies to transform the healthcare sector. As the flagship company of the Kothari Group, it maintains operations across India and has a presence in overseas markets.;
| Parent Organisation | Albert David Limited |
| Managing Director | Mr. Tarminder Parmar |
| NSE Symbol | ALBERTDAVD |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.77 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.74 | ||
| Cohance Lifesciences | NA (0.00%) | 75.16 | ||
| Wockhardt | NA (0.00%) | -428.76 |